Heart Surgery

Latest Issue of OR Manager
March 2025
Home Surgery/Specialties > Heart Surgery

Effectiveness of TAVR in intermediate-risk patients

Editor's Note In intermediate-risk patients, outcomes (ie, death from any cause or disabling stroke) of transcatheter aortic-valve replacement (TAVR) were similar to conventional open aortic-valve replacement, this study finds. The study involved 2,032 patients: 1,011 were randomized to TAVR and 1,021 to open surgery. Previous studies have shown that survival rates…

Read More

By: Judy Mathias
April 28, 2016
Share

Mini-MVR provides excellent outcomes without increased costs

Editor's Note Patients undergoing minimally invasive mitral valve repair or replacement (mini-MVR) have similar outcomes as patients having traditional open procedures and also experience shorter hospital stays and fewer blood transfusions, finds this study. The study included 1,304 patients, including 425 mini-MVRs. Compared with traditional MVR, Mini-MVR patients had similar…

Read More

By: Judy Mathias
March 31, 2016
Share

FDA: Class I recall of Arrow International Intra-Aortic Balloon Catheter Kits and Percutaneous Insertion Kits

Editor's Note The Food and Drug Administration (FDA) on March 11 announced the Class I recall of  Arrow International Intra-Aortic Balloon Catheter Kits and Percutaneous Insertion Kits by Teleflex Incorporated (Wayne, Pennsylvania). Class I is the FDA’s most serious recall classification. The Kits are being recalled because the sheath body…

Read More

By: Judy Mathias
March 14, 2016
Share

Long work hours tied to higher risk of CVD

Editor's Note Working 46 hours per week or more increases the long-term risk of cardiovascular disease (CVD), this study finds. Beginning at 46 hours, increasing work hours were progressively associated with increased risk of CVD (ie, angina, coronary disease, heart failure, heart attack, high blood pressure, or stroke). Compared to…

Read More

By: Judy Mathias
March 7, 2016
Share

Sponsored Message

FDA: Abbott issues safety notice for MitraClip Delivery System

Editor's Note The Food and Drug Administration on February 29 announced a safety notice issued by Abbott (Abbott Park, Illinois) to reinforce the proper procedures used to operate and deploy its MitraClip Delivery System. The company has received nine reports of device malfunction where the user was unable to separate…

Read More

By: Judy Mathias
March 2, 2016
Share

New guidelines recommend use of arterial grafts for coronary bypass

Editor's Note New clinical practice guidelines from the Society of Thoracic Surgeons recommend the use of arteries from the chest and forearm rather than using veins from the leg for coronary artery bypass grafting. The left internal thoracic artery is considered the gold standard conduit for coronary bypass and has…

Read More

By: Judy Mathias
December 8, 2015
Share

Sponsored Message

FDA: Boston Scientific recalls RotaWire Elite and wireClip Torquer Guidewires

Editor's Note Boston Scientific Corporation is recalling RotaWire Elite core wires because they may crack and separate from the rest of the Rotablator Rotational Atherectomy System and cause serious injury such as tamponade, myocardial infarction, and migration of wire fragments, the Food and Drug Administration reported November 27. Boston Scientific…

Read More

By: Judy Mathias
November 30, 2015
Share

Ultrasound-guided vs angiography-guided coronary stent implantation

Editor's Note In patients requiring long coronary stents, the use of intravascular ultrasound (IVUS)-guided vs angiography-guided drug-eluting stent implantation resulted in a significantly lower rate (2.9% absolute reduction, 48% relative reduction) of major adverse cardiac events at 1 year, finds this study. These differences were mainly driven by the reduction…

Read More

By: Judy Mathias
November 11, 2015
Share

Appropriate use criteria reduces nonacute, inappropriate PCIs

Editor's Note Since publication of the Appropriate Use Criteria for Coronary Revascularization in 2009, the number of nonacute percutaneous coronary interventions (PCIs) has declined significantly (89,704 vs 59,375). The proportion of nonacute PCIs classified as inappropriate has also declined (26.2% vs 13.3%), although hospital-level variation persists. These findings indicate that…

Read More

By: Judy Mathias
November 10, 2015
Share

FDA: Quest Medical recalls certain lots of Myocardial Protection System delivery sets

Editor's Note Quest Medical, Inc (Allen, Texas), on October 28 initiated a nationwide recall of its Myocardial Protection System delivery sets, Models 5001102, 5001102-AS, and 7001102 of specified lots. The sets have shown possible seal failure along the blood source channel of the main pump cassette, resulting in blood loss…

Read More

By: Judy Mathias
November 3, 2015
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat